Barne Medikuntza

2014

1. A survey of ATRIPLA use in clinical practice as first-line therapy in HIV-positive persons in Europe

   Infection, Vol. 42, Núm. 4, pp. 757-762

2. Abacavir/lamivudine plus darunavir/ritonavir in routine clinical practice: A multicentre experience in antiretroviral therapy-naive and -experienced patients

   Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 9

3. Aldosteronismo primario senil asociado a carcinoma suprarrenal funcionante

   Revista Clinica Espanola, Vol. 214, Núm. 6

4. Anti-vascular endothelial growth factor for proliferative diabetic retinopathy

   Cochrane Database of Systematic Reviews, Vol. 2014, Núm. 11

5. Basal ganglia calcification and seizures

   Medicina Clinica, Vol. 142, Núm. 3, pp. 140

6. Bilateral scalp necrosis in a patient with giant-cell arteritis

   Medicina Clinica, Vol. 142, Núm. 1, pp. 46

7. Characteristics of prosthetic joint infections due to Enterococcus sp. and predictors of failure: A multi-national study

   Clinical Microbiology and Infection, Vol. 20, Núm. 11, pp. 1219-1224

8. Compliance with national guidelines for HIV treatment and its association with mortality and treatment outcome: A study in a Spanish cohort

   HIV Medicine, Vol. 15, Núm. 2, pp. 86-97

9. Daptomycin is safe and effective for the treatment of gram-positive cocci infections in solid organ transplantation

   Transplant Infectious Disease, Vol. 16, Núm. 4, pp. 532-538

10. Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: The D:A:D study

    BMC Nephrology, Vol. 15, Núm. 1

11. Documento de consenso de GeSIDA/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana (Actualización enero 2014)

    Enfermedades Infecciosas y Microbiologia Clinica Monografias, Vol. 32, Núm. 7, pp. 446e1-446e42

12. Effectiveness of ritonavir-boosted protease inhibitor monotherapy in the clinical setting: Same results as in clinical trials? The PIMOCS study group

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 5, pp. 1390-1396

13. Effects of sustained viral response in patients with HIV and chronic hepatitis C and nonadvanced liver fibrosis

    Journal of Acquired Immune Deficiency Syndromes, Vol. 66, Núm. 3, pp. 280-287

14. El Dr. Iñaki Azkuna y la Academia de Ciencias Médicas de Bilbao

    Gaceta médica de Bilbao: Revista oficial de la Academia de Ciencias Médicas de Bilbao. Información para profesionales sanitarios, Vol. 111, Núm. 2

15. Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: A population-based surveillance in Spain

    Clinical Microbiology and Infection, Vol. 20, Núm. 4

16. Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2014)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 32, Núm. 7, pp. 447-458

17. Executive summary of the recommendations on the evaluation and management of renal disease in human immunodeficiency virus-infected patients

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 32, Núm. 9, pp. 583-597

18. Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus

    Rheumatology (United Kingdom), Vol. 53, Núm. 8, pp. 1470-1476

19. Gram-negative prosthetic joint infection: Outcome of a debridement, antibiotics and implant retention approach. A large multicentre study

    Clinical Microbiology and Infection, Vol. 20, Núm. 11, pp. O911-O919

20. HIV/hepatitis C virus-coinfected patients who achieved sustained virological response are still at risk of developing hepatocellular carcinoma

    AIDS, Vol. 28, Núm. 1, pp. 41-47